FDA Approves Aerie's Glaucoma Treatment

Tuesday, 19 December 2017 08:49 AM

(Reuters) - Aerie Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration approved its treatment for glaucoma, Rhopressa.

The approval was given two months ahead of the expected date, the company said.


(Reporting by Tamara Mathias in Bengaluru; Editing by Arun Koyyur)

© 2018 Thomson/Reuters. All rights reserved.

1Like our page
Tuesday, 19 December 2017 08:49 AM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved